Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
15 hedge funds and large institutions have $1.87M invested in Novo Integrated Sciences, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
475% more capital invested
Capital invested by funds: $325K → $1.87M (+$1.54M)
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
7% more funds holding
Funds holding: 14 → 15 (+1)
2.43% more ownership
Funds ownership: 1.52% → 3.94% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$533K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$203K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$76.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$28.8K |
| 5 |
Jane Street
New York
|
+$9.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$35K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$20.4K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$19.3K |
| 4 |
AWM
Axxcess Wealth Management
Carlsbad,
California
|
-$8.15K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.23K |
NVOS Hedge Fund Activity: Q3 2023 in Review
15 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q3 2023, worth a combined $1.87M — up 475% from $325K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NVOS positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $533K. The largest seller was Virtu Financial, exiting entirely with an estimated $35K sold.
- 15 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q3 2023, up from 14 in Q2 2023.
- Funds reported $1.87M of Novo Integrated Sciences, Inc. Common Stock stock for Q3 2023, up 475% quarter-over-quarter.
- 6 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q3 2023 and 5 closed out, a net change of +1 holder.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q3 2023 was BlackRock, an estimated $533K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q3 2023 was Virtu Financial, an estimated $35K sold.
Based on aggregated 13F filings for Q3 2023.